Effects of Using Free Sample Medications on the Prescribing Practices of Family Physicians

References

1. ↵
   California Healthcare Institute. Another drug cost crisis looms [article on the Internet]. 2003 Sept [cited 2004 Mar 8]. Available from: http://chi.org/home/article.php?pid=589.
2. ↵
   IMS Health. World drug purchases-retail pharmacies, IMS Health-drug monitor: 12 months to February 2000 [document on Internet]. 2000 [cited 2004 Mar 8]. Available from: http://ww0.ne.imshealth.com/public/structure/attachment/1%2C2823%2C250%2C00.pdf.
3. ↵
   IMS Health. Key country drug purchases-retail pharmacies, IMS Health-retail drug monitor: 12 months to May 2003 [document on Internet]. 2003 [cited 2004 Mar 8]. Available from: http://www.w.open.imshealth.com/download/may2003.pdf.
4. ↵
   Ma J, Stafford RS, Cockbum IM, Findelstein SN. A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998. Clin Ther 2003; 25: 1503–18.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   Henry J. Kaiser Family Foundation. National survey of physicians, part II: doctors and prescription drugs [document on the Internet]. 2002. [cited 2004 Sept]. Available from: http://www.kff.org/rxdrugs/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=13965.
6. ↵
   Westfall JM. Physicians. Pharmaceutical representatives, and patients: who really benefits? J Fam Pract 2000; 49: 817–9.

   OpenUrlPubMedWeb of Science
7. ↵
   Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA 2000; 283: 373–80.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   Guldal D, Semin S. The influences of drug companies’ advertising programs on physicians. Int J Health Serv 2000; 30: 585–95.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   Chew LD, O’Young TS, Hazlet TK, Bradley KA, Lessler DS. A physician survey of the effect of drug sample availability on physicians’ behavior. J Gen Intern Med 2000; 15: 478–84.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Elling ME, Fogle HJ, McKhann CS, Simon C. Making more of pharms’s sales force [article on the Internet]. The McKinsey Quarterly 2002 Jun [cited 2004 Sept 4];102(6). Available from: http://www.mckinseyquarterly.com/.
11. ↵
    Tong KL, Lien CY. Do pharmaceutical representatives misuse their drug samples? Can Fam Physician 1995; 41: 1363–6.

    OpenUrlPubMedWeb of Science
12. ↵
    Westfall JM, McCabe J, Nicholas RA. Personal use of drug samples by physicians and office staff. JAMA 1997; 278: 141–143.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Wang TJ, Ausiello JC, and Stafford RS. Trends in antihypertensive drug advertising. Circulation 2003; 99: 2055–7.

    OpenUrl
14. ↵
    Groves KE, Sketris I, Tett SE. Prescription drug samples—does this marketing strategy counteract policies for quality use of medicines? J Clin Pharm Ther 2003; 28: 90–109.

    OpenUrl
15. ↵
    Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med 2003; 163: 2213–8.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    Backer EL, Lebsack JA, Van Tonder RJ, Crabtree BF. The value of pharmaceutical representative visits and medication samples in community-based family practices. J Fam Pract 2000; 49: 811–6.

    OpenUrlPubMedWeb of Science